Skip to main content
Premium Trial:

Request an Annual Quote

Novocell, Invitrogen

Novocell, a stem cell engineering company headquartered in San Diego, Calif., this week announced the launch of STEMPRO hESC SFM, a fully-defined, serum- and feeder-free media specifically formulated for the growth and expansion of human embryonic stem cells.
The product will be sold by Invitrogen under a licensing agreement with Novocell.
Accoding to the companies, STEMPRO hESC SFM is the first serum- and feeder-free media for hESCs that has been shown to maintain these cells in a genetically normal state. STEMPRO hESC SFM has been extensively tested and proven to keep hESCs pluripotent in a number of lines, including BG01, BG02, BG03, HUES9, H1, and H9.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.